Related Experiment Videos
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity
D N Gilbert1, C A Wood, S J Kohlhepp
1Chiles Research Institute, Providence Medical Center, Portland, OR 97213.
The Journal of Infectious Diseases
|May 1, 1989
Summary
Polyspartic acid (PAA) effectively prevented gentamicin-induced kidney damage in experimental models. This polyamino acid protected kidney function and pathology without affecting gentamicin
Area of Science:
- Nephrology
- Pharmacology
- Toxicology
Background:
- Aminoglycosides are essential antibiotics but can cause kidney damage (nephrotoxicity).
- Polyspartic acid (PAA) is a polyamino acid with potential therapeutic applications.
Purpose of the Study:
- To investigate the protective effects of PAA against experimental aminoglycoside nephrotoxicity.
Main Methods:
- Animal models were used to assess gentamicin nephrotoxicity.
- PAA was administered alone or with gentamicin.
- Renal function, pathology, and drug accumulation were evaluated.
- In vitro antimicrobial activity was tested.
Main Results:
- PAA completely prevented functional and pathological signs of gentamicin nephrotoxicity for up to 27 days.
- PAA administration led to distinct cytoplasmic vacuoles in renal tubular cells.
- Rats receiving PAA plus gentamicin accumulated 10 times more renal aminoglycoside.
- Immunohistochemistry confirmed increased gentamicin in tubular cells with PAA co-administration.
Conclusions:
- PAA demonstrates a significant ability to prevent experimental gentamicin nephrotoxicity.
- PAA's protective mechanism may involve altered drug accumulation within renal tubules.
- PAA did not compromise the in vitro antibacterial efficacy of gentamicin.